MARK activation in human blood mononuclear cells in types 1 and 2 diabetes

by V. V. Pushkarov, L. K. Sokolova, O. I. Kovzun, S. A. Cherviakova, T. S. Vatseba, V. M. Pushkarov, M. D. Tronko
Published 2020

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

by M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova
Published 2021

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients

by M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchina, O. I. Kovzun, V. M. Pushkarev
Published 2021

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease

by V. V. Pushkarov, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchyna, O. I. Kovzun, V. M. Pushkarov, M. D. Tronko
Published 2021

Untitled

by M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova
Published 2021

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients

by M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Y. B. Belchina, O. I. Kovzun, B. B. Guda, V. M. Pushkarev
Published 2022

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

by L. K. Sokolova, V. M. Pushkarev, Yu. B. Belchina, V. V. Pushkarev, O. V. Furmanova, S. A. Cherviakova, O. I. Kovzun, M. D. Tronko
Published 2018